Search Results - "Guerrero, A. Sánchez"

Refine Results
  1. 1

    Combination of soil organic and inorganic amendments helps plants overcome trace element induced oxidative stress and allows phytostabilisation by Clemente, R., Arco-Lázaro, E., Pardo, T., Martín, I., Sánchez-Guerrero, A., Sevilla, F., Bernal, M.P.

    Published in Chemosphere (Oxford) (01-05-2019)
    “…Trace element (TE)-contaminated soils require the improvement of their physico-chemical properties in order to allow their restoration through…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Spinal cord injury associated with spontaneous spinal epidural hematoma by Sánchez Guerrero, A M, Alcobendas-Maestro, M, Palazón García, R, Cofiño Rodríguez, S M

    Published in Rehabilitacion (01-10-2023)
    “…Spontaneous spinal epidural hematoma (SSEH) is a disease with low incidence and high morbidity/mortality. It can cause severe loss of function. In order to…”
    Get more information
    Journal Article
  4. 4

    Economic impact of the new oral treatments for multiple sclerosis by Álvarez Ayuso, L, Rodríguez Marrodán, B, Blasco Quílez, M R, García-Merino, J A, Sánchez Guerrero, A

    Published in Neurología (Barcelona, English ed. ) (01-03-2021)
    “…INTRODUCTIONMultiple sclerosis (MS) is a chronic disease affecting the central nervous system and is characterised by inflammation, demyelination, gliosis, and…”
    Get full text
    Journal Article
  5. 5

    Major As species, lipid peroxidation and protein carbonylation in rice plants exposed to increasing As(V) concentrations by Álvarez-Robles, M.J., Bernal, M.P., Sánchez-Guerrero, A., Sevilla, F., Clemente, R.

    Published in Heliyon (01-08-2020)
    “…Arsenic (As) uptake by plants is mainly carried out as arsenate (As(V)), whose chemical analogy with phosphate is largely responsible for its elevated…”
    Get full text
    Journal Article
  6. 6

    Economic impact of the new oral treatments for multiple sclerosis by Álvarez Ayuso, L., Rodríguez Marrodán, B., Blasco Quílez, M.R., García-Merino, J.A., Sánchez Guerrero, A.

    Published in Neurología (Barcelona, English ed. ) (01-03-2021)
    “…Multiple sclerosis (MS) is a chronic disease affecting the central nervous system and is characterised by inflammation, demyelination, gliosis, and axonal…”
    Get full text
    Journal Article
  7. 7
  8. 8

    CP-163 Analysis of the side effects and the treatment discontinuation of dimethyl fumarate in a tertiary hospital by De Rivas Bravo, A, Alonso, A Martín, Viso, B Menchén, Olias, C Folguera, Nombela, A Maestro, Guerrero, A Sánchez

    “…BackgroundMultiple sclerosis (MS) involves an immune mediated process in which an abnormal response of the body’s immune system is directed against the central…”
    Get full text
    Journal Article
  9. 9

    PS-068 Evaluation of the incidence and the consequences of the extravasation of chemotherapy drugs in a tertiary hospital by Alonso, A Martín, Bravo, A de Rivas, Manrique, M Manso, Prieto, E Santiago, Guerrero, A Sánchez

    “…BackgroundCytostatic extravasation is the inadvertent leakage of intravenous anticancer agents out of the vein into surrounding tissue. Extravasation is only…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Anti-SARS-CoV-2 vaccination in patients with hematological disorders: A case-control study by Sergio A. Sánchez-Guerrero

    Published in Medicina Universitaria (24-10-2022)
    “…Background: COVID-19 pandemics arrived to Mexico in March 2020, and in year 2021, a national vaccination program for adult population was implemented…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    4CPS-176 Psychiatric disorders and cardiopulmonary arrest probably related to prescribing cascade by Álvarez, A Repilado, Quirós, V Saavedra, Cerezuela, MD García, Baena, I Gumiel, Guerrero, A Sánchez

    “…BackgroundPrescribing cascade is the situation in which a first drug administered to a patient causes adverse reactions that are misinterpreted as a new…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    4CPS-255 Expanding the process of pharmaceutical care to the institutionalised patient care unit by Quirós, V Saavedra, Pueyo, R Capilla, Hamelin, I Roch, Carrizo, A Medina, Mateos, MA Gómez, Guerrero, A Sánchez

    “…BackgroundThe Institutionalised Patient Care Unit (IPCU) aims to humanise and optimise the care of the institutionalised older patients in the Emergency…”
    Get full text
    Journal Article
  18. 18

    Impacto económico de las nuevas terapias orales en esclerosis múltiple by Álvarez Ayuso, L., Rodríguez Marrodán, B., Blasco Quílez, M.R., García-Merino, J.A., Sánchez Guerrero, A.

    Published in Neurología (Barcelona, Spain) (01-03-2021)
    “…La esclerosis múltiple (EM) es una enfermedad crónica del sistema nervioso central que se caracteriza por la existencia de inflamación, desmielinización,…”
    Get full text
    Journal Article
  19. 19

    Medication reconciliation at admission and discharge. A consolidated experience by Saavedra-Quirós, V, Montero-Hernández, E, Menchén-Viso, B, Santiago-Prieto, E, Bermejo-Boixareu, C, Hernán-Sanz, J, Sánchez-Guerrero, A, Campo Loarte, J

    Published in Revista de calidad asistencial (01-06-2016)
    “…Medication reconciliation is currently one of the main strategies to reduce medication errors related to transitional care. To describe a method that would…”
    Get full text
    Journal Article
  20. 20

    Serum hyperviscosity syndrome responding to therapeutic plasmapheresis in a patient with primary Sjögren's syndrome by Simón, J. Abraham, Lazo-Langner, Alejandro, Duarte-Rojo, Andrés, Velázquez-González, Antonio, Sánchez-Guerrero, Sergio A., Sánchez-Guerrero, Jorge

    Published in Journal of clinical apheresis (2002)
    “…Hyperviscosity syndrome is a disorder first described in patients with Waldenström's macroglobulinemia and is not commonly seen in rheumatic diseases. Its…”
    Get full text
    Journal Article